For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
Population Health Sciences

You are here

Publications

Found 349 results
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is S  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
O
Goyal P, Ringel JBryan, Rajan M, Choi JJ, Pinheiro LC, Li HA, Wehmeyer GT, Alshak MN, Jabri A, Schenck EJ et al..  2020.  Obesity and COVID-19 in New York City: A Retrospective Cohort Study.. Ann Intern Med.
Goyal P, Ringel JBryan, Rajan M, Choi JJ, Pinheiro LC, Li HA, Wehmeyer GT, Alshak MN, Jabri A, Schenck EJ et al..  2020.  Obesity and COVID-19 in New York City: A Retrospective Cohort Study.. Ann Intern Med.
Goyal P, Ringel JBryan, Rajan M, Choi JJ, Pinheiro LC, Li HA, Wehmeyer GT, Alshak MN, Jabri A, Schenck EJ et al..  2020.  Obesity and COVID-19 in New York City: A Retrospective Cohort Study.. Ann Intern Med.
Hajifathalian K, Kumar S, Newberry C, Shah S, Fortune B, Krisko T, Ortiz-Pujols S, Zhou XKathy, Dannenberg AJ, Kumar R et al..  2020.  Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City.. Obesity (Silver Spring).
Hajifathalian K, Kumar S, Newberry C, Shah S, Fortune B, Krisko T, Ortiz-Pujols S, Zhou XKathy, Dannenberg AJ, Kumar R et al..  2020.  Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City.. Obesity (Silver Spring).
Greenlee H, Shi Z, Hibshoosh H, Giri DD, Ahmed A, Williams S, Falcone DJ, Winston LA, Zhou XK, Hudis CA et al..  2019.  Obesity-associated Breast Inflammation among Hispanic/Latina Breast Cancer Patients.. Cancer Prev Res (Phila). 12(1):21-30.
Turchioe MReading, Grossman LV, Baik D, Lee CS, Maurer MS, Goyal P, Safford MM, Creber RMMasterso.  2020.  Older Adults Can Successfully Monitor Symptoms Using an Inclusively Designed Mobile Application.. J Am Geriatr Soc.
Aviki EM, Schleicher SM, Mullangi S.  2019.  The Oncology Care Model and Other Value-Based Payment Models in Cancer Care.. JAMA Oncol. 5(3):298-299.
Mones E, Stopczynski A, Pentland A'Sandy', Hupert N, Lehmann S.  2018.  Optimizing targeted vaccination across cyber-physical networks: an empirically based mathematical simulation study.. J R Soc Interface. 15(138)
Glass HC, Grinspan ZM, Shellhaas RA.  2018.  Outcomes after acute symptomatic seizures in neonates.. Semin Fetal Neonatal Med. 23(3):218-222.
Morgan JR, Schackman BR, Weinstein ZM, Walley AY, Linas BP.  2019.  Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort.. Drug Alcohol Depend. 200:34-39.
P
McHugh M, Shi Y, Ramsay PP, Harvey JB, Casalino LP, Shortell SM, Alexander JA.  2016.  Patient-Centered Medical Home Adoption: Results From Aligning Forces For Quality.. Health Aff (Millwood). 35(1):141-9.
McHugh M, Shi Y, Ramsay PP, Harvey JB, Casalino LP, Shortell SM, Alexander JA.  2016.  Patient-Centered Medical Home Adoption: Results From Aligning Forces For Quality.. Health Aff (Millwood). 35(1):141-9.
Vest JR, Kern LM, Jung H-Y, Ancker JS, Richardson JE, Silver MD, Kaushal R.  2015.  Patient-centered medical homes: observable types derived from national recognition assessment scores.. J Ambul Care Manage. 38(2):144-52.
Kern LM, Grinspan Z, Shapiro JS, Kaushal R.  2017.  Patients' Use of Multiple Hospitals in a Major US City: Implications for Population Management.. Popul Health Manag. 20(2):99-102.
Hearld LR, Alexander JA, Shi Y, Casalino LP.  2014.  Pay-for-performance and public reporting program participation and administrative challenges among small- and medium-sized physician practices.. Med Care Res Rev. 71(3):299-312.
Batra JS, Niaz MJunaid, Whang YE, Sheikh A, Thomas C, Christos P, Vallabhajosula S, Jhanwar YS, Molina AM, Nanus DM et al..  2020.  Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.. Urol Oncol.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.
Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al..  2019.  A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.